OSLO, Norway, March 14, 2025 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study “Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO study” in JU Open Plus this week. The research objective…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.